AzTrials
AzTrials

AttentionFoCoNCT04362397

FoCo: Evaluating a Training to Increase Attention and Awareness of Healthcare Professionals

A study testing FoCo in people with Attention and Self-compassion, run by Hospital Israelita Albert Einstein at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Introduction: A significant increase in the risk of injury and illness at work has been associated with fatigue, stress, haste, distraction, emergency situations, excessive noise, complex procedures and anger among other factors. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Attention, Self-compassion
What is being tested?
FoCo
Could I receive a placebo?
No, everyone receives an active treatment
How many people
190 participants
Where
1 siteBrazil
Study dates
20 Aug 2019to 20 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • be available to participate in the training and to perform the evaluations before and after it.

Who cannot join

  • being away or on vacation during the research project, being in psychiatric treatment.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Hospital Israelita Albert Einstein

    São Paulo, 05652901

Other trials in Brazil

About this study

Official title: Foco: Evaluating a Training to Increase Attention and Awareness in the Daily Activities of Healthcare Professionals

Introduction: A significant increase in the risk of injury and illness at work has been associated with fatigue, stress, haste, distraction, emergency situations, excessive noise, complex procedures and anger among other factors.

Most of these factors are related to the lack of attention to work in progress, which can be improved by training attention and awareness during daily activities, as it would encourage a resumption of focus on the task at hand and the possible risks associated with it. . The primary objective of this project is to evaluate the effects of training to increase attention and awareness for daily activities - FoCo - outlined for healthcare professionals in their work schedule. Method: Health professionals from 18 to 60 years of age, of both sexes, will participate in the study, working in 3 units, one in the care of patients in a Emergency Care Unit (UPA), in an Elderly Residential and in a Center. Intensive Care (ICU). In the UPA will be included 25 professionals in group A and 25 in group B; In the Residential of Elderly, 40 professionals will be included in group A and 40 professionals in group B; In the ICU will be included 30 professionals in group A and 30 in group B. They will be randomized in both groups. Group A will receive training in the FoCo program and group B will be a waiting group. After a period of one month, group B will receive training in FoCo and group A will be instructed to continue on their own to apply FoCo in their daily lives (Fig.1). Participants will be evaluated before, after one month and after two months. Expected Outcomes: After training, an increase in mindful, attention and awareness scale, self-compassion scale, positive affect, speed of digit and symbol test is expected. It is also expected to reduce negative affects, perceived stress and an increased perception of possible incidents.

Being tested
FoCo, No intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FoCoBehavioural

    This is an attention, care and self-care training.

  • No interventionBehavioural

    This is a waiting list

Study groups in NCT04362397
Study groupRoleWhat they receive
A (first group to receive the intervention)ExperimentalThis arm will receive the attention, care, and self-care training first.
Receives: Behavioral: FoCo; Behavioral: No intervention
B (second group to receive the intervention)ExperimentalThis arm will not receive intervention in the first month and will receive it after this period.
Receives: Behavioral: FoCo; Behavioral: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in stress

    The authors will evaluate attention using the MAAS (Mindful Attention Awareness Scale).

    Measured: 1 month

  2. change in attention

    The authors will apply the Perceived Stress Scale

    Measured: 1 month

Secondary outcomes (4)
  1. change in self-compassion

    The authorswill apply the self-compassion scale

    Measured: 1 month

  2. change in sleep

    The authors will apply the Pittsburgh inventory

    Measured: 1 month

  3. change in Mental health symptoms

    The authors will apply the SRQ-20 (self-report questionnaire)

    Measured: 1 month

  4. change in positive and negative affect

    The authors will apply PANAS

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2020
  2. Study start20 Aug 2019
  3. Primary completion20 May 2020
  4. Study completion20 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Crossover
Model description
Group A will receive training in the FoCo program and group B will be a waiting list group. After a period of one month, group B will receive training in FoCo and group A will be instructed to continue on their own to apply FoCo in their daily lives.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
190 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04362397
Sponsor's protocol ID
HIAE_FoCo
Acronym
FoCo
Status last verified
Dec 2019
First submitted
19 Dec 2019
Last updated
11 Feb 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing FoCo in people with Attention and Self-compassion, run by Hospital Israelita Albert Einstein at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in stress (time frame: 1 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in